Cas:578714-82-6 (1R,2S,5R,6R,7S)-7-Ethyl-1,6-dimethyltricyclo[4.2.1.12,5]decan-9-one manufacturer & supplier

Chemical Name:(1R,2S,5R,6R,7S)-7-Ethyl-1,6-dimethyltricyclo[4.2.1.12,5]decan-9-one

CAS.NO:578714-82-6

Synonyms:(1R,2S,5R,6R,7S)-7-Ethyl-1,6-dimethyltricyclo[4.2.1.12,5]decan-9-one

Molecular Formula:C₁₄H₂₂O

Molecular Weight:206.32400

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:17.07000

Exact Mass:206.16700

LogP:3.42790

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like (1R,2S,5R,6R,7S)-7-Ethyl-1,6-dimethyltricyclo[4.2.1.12,5]decan-9-one chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,(1R,2S,5R,6R,7S)-7-Ethyl-1,6-dimethyltricyclo[4.2.1.12,5]decan-9-one physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,(1R,2S,5R,6R,7S)-7-Ethyl-1,6-dimethyltricyclo[4.2.1.12,5]decan-9-one Use and application,(1R,2S,5R,6R,7S)-7-Ethyl-1,6-dimethyltricyclo[4.2.1.12,5]decan-9-one technical grade,usp/ep/jp grade.

Related News: The government will also send a charter flight with an Air New Zealand crew to repatriate up to 300 citizens in Wuhan. (1R,2S,5R,6R,7S)-7-Ethyl-1,6-dimethyltricyclo[4.2.1.12,5]decan-9-one manufacturer Many domestic raw material pharmaceutical and intermediate manufacturing companies with strong capital and talent reserves and advanced technology and processes have developed in the country, and the competitiveness of market participants has continued to increase. (1R,2S,5R,6R,7S)-7-Ethyl-1,6-dimethyltricyclo[4.2.1.12,5]decan-9-one supplier Safety concerns about the J&J vaccine paired with flagging U.S. demand for vaccinations in general have slowed rollout of the one-shot vaccine to a crawl. Close to half of the 21 million doses produced for the United States sit unused. (1R,2S,5R,6R,7S)-7-Ethyl-1,6-dimethyltricyclo[4.2.1.12,5]decan-9-one vendor Retrogenix and Resonant Therapeutics, Inc. recently announced they have entered into a non-exclusive strategic partnership to identify the targets of Resonant antibodies directed against the tumor microenvironment. (1R,2S,5R,6R,7S)-7-Ethyl-1,6-dimethyltricyclo[4.2.1.12,5]decan-9-one factory Many domestic raw material pharmaceutical and intermediate manufacturing companies with strong capital and talent reserves and advanced technology and processes have developed in the country, and the competitiveness of market participants has continued to increase.